0001193805-17-001422.txt : 20170804 0001193805-17-001422.hdr.sgml : 20170804 20170804182353 ACCESSION NUMBER: 0001193805-17-001422 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170802 FILED AS OF DATE: 20170804 DATE AS OF CHANGE: 20170804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEFF JONATHAN S CENTRAL INDEX KEY: 0001215242 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 171009716 MAIL ADDRESS: STREET 1: C/O DEERFIELD MANAGEMENT COMPANY, L.P STREET 2: 780 THIRD AVENUE, 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-0102 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 e616444_4-proteon.xml OWNERSHIP DOCUMENT X0306 4 2017-08-02 0 0001359931 PROTEON THERAPEUTICS INC PRTO 0001215242 LEFF JONATHAN S C/O PROTEON THERAPEUTICS, INC. WALTHAM MA 02451 1 0 0 0 Stock Option (Right to Buy) 1.30 2017-08-02 4 A 0 13333 0 A 2027-08-01 Common Stock 13333 13333 D The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the option for the benefit, and at the direction, of Deerfield Management Company, L.P. The option shall vest and become exercisable with respect to one-third of the shares on each of August 2, 2018, August 2, 2019 and August 2, 2020. /s/ Jonathan S Leff 2017-08-04